Observational Non-Interventional Study Evaluating the Safety and Efficacy of Truvada [emtricitabine/tenofovir disoproxil fumarate] + Nevirapine.
Phase of Trial: Phase IV
Latest Information Update: 04 Jun 2014
At a glance
- Drugs Nevirapine (Primary) ; Emtricitabine/tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 10 Jun 2017 Biomarkers information updated
- 15 Jan 2010 Actual end date (December 2009) added as reported by ClinicalTrials.gov.
- 15 Jan 2010 Actual patient number (331) added as reported by ClinicalTrials.gov.